•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.TRUQAP® (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer
Patterson-UTI (PTEN) is a Great Momentum Stock: Should You Buy?
Patterson-UTI Reports Drilling Activity for May 2026
Is PattersonUTI Energy (PTEN) Outperforming Other Oils-Energy Stocks This Year?
Patterson-UTI Energy Inc (PTEN) Shares Fall 5.3% -- What GF Score of 56 Tells Investors
Sourcerock Group Adds to Patterson-UTI Energy Stake, According to Recent SEC Filing
3 Oil & Gas Drilling Stocks With Strong Upside Potential
Patterson-UTI (PTEN) Up 9.6% Since Last Earnings Report: Can It Continue?
FLOC vs. PTEN: Which Oilfield Services Stock Looks Better?
What Makes Patterson-UTI (PTEN) a Strong Momentum Stock: Buy Now?
Is PattersonUTI Energy (PTEN) a Great Value Stock Right Now?
A PTEN Director Sold $123K in Shares - what he kept adds context
Why This Fund’s $8 Million Patterson-UTI Bet Looks Like a Bullish Oil Recovery Trade
Patterson-UTI Reports Drilling Activity for April 2026
Here's Why Patterson-UTI (PTEN) is a Great Momentum Stock to Buy
Patterson-UTI Energy Q1 Earnings & Revenues Beat Estimates
Are Oils-Energy Stocks Lagging Bloom Energy (BE) This Year?
Patterson-UTI Energy, Inc. (PTEN) Q1 2026 Earnings Call Transcript
Patterson-UTI Energy Inc (PTEN) Stock Up 3.0% but GF Value Says Overvalued -- GF Score: 68/100
Compared to Estimates, Patterson-UTI (PTEN) Q1 Earnings: A Look at Key Metrics